Cboe Global Markets Inc. (0HQN)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 308.06 |
|---|---|
| 52-week range | 226.36 – 377.07 |
| Return, 1 month / 3 months | +15.0% / +11.5% |
| Return, 1 year / 3 years | +30.4% / +110.9% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 35.9% |
| Worst drawdown (1 year) | -36.5% |
| Average daily value traded | 0.11M USD |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cboe Global Markets is an exchange operator based in Chicago that runs markets for options, futures and equities trading. It provides trading venues and related services to brokers, banks, asset managers and other market participants, and it is known for volatility products tied to its own index methodology. The company also offers market data and access services to customers around the world, connecting traders to its electronic platforms.
The shares are listed on the London Exchange in UK under the code 0HQN, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cboe Global Markets Inc. (0HQN) trades on the London Exchange in UK. It last closed at USD 308.06 on 19 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 1,969 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 30.4% and over the last three months it rose 11.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.0% | ||
| From 52-week high | -16.2% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 11.5% | ||
| 6-month return | 1.5% | ||
| 12-month return, skipping the last month | 13.3% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.5% | ||
| Liquidity | 31 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.11M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +15.0% |
| 3 months | +11.5% |
| 6 months | +1.5% |
| 1 year | +30.4% |
| 3 years | +110.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 288.01 / 287.91 |
|---|---|
| Golden / death cross (60 days) | Golden, 0 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 13.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | USD 0.8600 |
| 28 May 2026 | USD 0.7200 |
| 26 Feb 2026 | USD 0.7200 |
| 27 Nov 2025 | USD 0.7200 |
| 28 Aug 2025 | USD 0.7200 |
| 29 May 2025 | USD 0.6300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.